home / stock / hoth / hoth news


HOTH News and Press, Hoth Therapeutics Inc. From 12/09/19

Stock Information

Company Name: Hoth Therapeutics Inc.
Stock Symbol: HOTH
Market: NASDAQ
Website: hoththerapeutics.com

Menu

HOTH HOTH Quote HOTH Short HOTH News HOTH Articles HOTH Message Board
Get HOTH Alerts

News, Short Squeeze, Breakout and More Instantly...

HOTH - Hoth Therapeutics And North Carolina State University Initiate Preclinical Gene Therapy Study For The Treatment Of Asthma

NEW YORK , Dec. 9, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, is pleased to an...

HOTH - Hoth Therapeutics to Present at the LD Micro Main Event (XII)

NEW YORK, NY / ACCESSWIRE / December 2, 2019 / Hoth Therapeutics, Inc. (NASDAQ:HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today annou...

HOTH - Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy

NEW YORK , Nov. 26, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today announced...

HOTH - Hoth Therapeutics to Attend Benchmark's 8th Annual Discovery 1x1 Conference

NEW YORK , Nov. 18, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today anno...

HOTH - Hoth Therapeutics Initiates Preclinical Study Including Topical Form of Aprepitant for Dermatological Treatment Relating to Side Effects of Cancer Medication

NEW YORK , Nov. 14, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today announced...

HOTH - Global Revenues for Atopic Dermatitis Market Expected to Grow to $18.3Billion by 2027

November 6, 2019 Palm Beach, FL – November 6, 2019 –  Atopic dermatitis is a widespread chronic inflammatory skin condition that can affect patients of all ages and is the result of a complex interplay of environmental, immunological, genetic, and pharmacologic fact...

HOTH - Hoth Therapeutics Initiates Confirmatory Study for Lupus Treatment

NEW YORK , Nov. 6, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq:HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as ...

HOTH - Hoth Therapeutics up 36%

Ultra-thinly traded Hoth Therapeutics ( HOTH +36.3% ) is up on a 5x surge in volume, albeit on turnover of only 51K shares, on no apparent news. More news on: Hoth Therapeutics, Inc., Spherix Incorporated, Healthcare stocks news, Stocks on the move, Read more ...

HOTH - FOMC, Streaming Wars And JEDI In Focus (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch to s...

HOTH - Stocks To Watch: FOMC, Streaming Wars And JEDI In Focus

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Previous 10 Next 10